Viridien
Short position disclosed on October 21, 2026.
10.49% of the capital sold short
9 disclosing funds
2,528 disclosures on record
Evolution of the disclosed total
0%5%10%15%
Jan 2026Apr 2026Jul 2026Oct 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Marshall Wace LLP | 1.99% | unchanged | October 20, 2026 | ||
| Capital Fund Management | 1.69% | new | October 19, 2026 | ||
| Citadel Advisors LLC | 1.46% | new | October 21, 2026 | ||
| Worldquant, LLC | 1.29% | new | October 15, 2026 | ||
| Acadian Asset Management LLC | 1.10% | new | October 19, 2026 | ||
| Tudor Capital Europe LLP | 0.80% | new | October 1, 2026 | ||
| Walleye Capital LLC | 0.80% | new | October 5, 2026 | ||
| TWO Sigma Investments, LP | 0.79% | new | October 19, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 15,164 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| February 1, 2023 | Qube Research & Technologies Limited | 0.71% | March 4, 2024 | |
| January 31, 2023 | Marshall Wace LLP | 2.70% | August 15, 2023 | |
| January 26, 2023 | Marshall Wace LLP | 2.62% | August 15, 2023 | |
| January 25, 2023 | Qube Research & Technologies Limited | 0.69% | March 4, 2024 | |
| January 23, 2023 | Marshall Wace LLP | 2.50% | August 15, 2023 | |
| January 19, 2023 | Qube Research & Technologies Limited | 0.79% | March 4, 2024 | |
| January 18, 2023 | Qube Research & Technologies Limited | 0.68% | March 4, 2024 | |
| January 17, 2023 | Qube Research & Technologies Limited | 0.72% | March 4, 2024 | |
| January 16, 2023 | Marshall Wace LLP | 2.45% | August 15, 2023 | |
| January 16, 2023 | Qube Research & Technologies Limited | 0.60% | March 4, 2024 | |
| January 13, 2023 | Qube Research & Technologies Limited | 0.48% | January 17, 2023 | |
| January 12, 2023 | Qube Research & Technologies Limited | 0.56% | January 17, 2023 | |
| January 10, 2023 | Marshall Wace LLP | 2.37% | August 15, 2023 | |
| January 10, 2023 | Qube Research & Technologies Limited | 0.68% | January 17, 2023 | |
| January 9, 2023 | Marshall Wace LLP | 2.55% | August 15, 2023 | |
| January 6, 2023 | Marshall Wace LLP | 2.60% | August 15, 2023 | |
| January 6, 2023 | Citadel Advisors LLC | 0.49% | January 10, 2023 | |
| January 4, 2023 | Marshall Wace LLP | 2.51% | August 15, 2023 | |
| January 4, 2023 | Citadel Advisors LLC | 0.75% | January 10, 2023 | |
| January 3, 2023 | Citadel Advisors LLC | 0.90% | January 10, 2023 | |
| December 30, 2022 | Marshall Wace LLP | 2.40% | August 15, 2023 | |
| December 29, 2022 | Marshall Wace LLP | 2.36% | August 15, 2023 | |
| December 29, 2022 | Citadel Advisors LLC | 0.87% | January 10, 2023 | |
| December 28, 2022 | Citadel Advisors LLC | 0.96% | January 10, 2023 | |
| December 22, 2022 | Marshall Wace LLP | 2.22% | August 15, 2023 | |
| December 20, 2022 | Marshall Wace LLP | 2.10% | August 15, 2023 | |
| December 20, 2022 | Voleon Capital Management LP | 0.41% | December 22, 2022 | |
| December 19, 2022 | Marshall Wace LLP | 1.96% | August 15, 2023 | |
| December 16, 2022 | Marshall Wace LLP | 1.86% | August 15, 2023 | |
| December 16, 2022 | Citadel Advisors LLC | 1.04% | January 10, 2023 | |
| December 16, 2022 | Voleon Capital Management LP | 0.58% | December 22, 2022 | |
| December 15, 2022 | Marshall Wace LLP | 1.71% | August 15, 2023 | |
| December 15, 2022 | Voleon Capital Management LP | 0.68% | December 22, 2022 | |
| December 14, 2022 | Voleon Capital Management LP | 0.74% | December 22, 2022 | |
| December 14, 2022 | Capital Fund Management | 0.45% | December 16, 2022 | |
| December 13, 2022 | Marshall Wace LLP | 1.63% | August 15, 2023 | |
| December 13, 2022 | Citadel Advisors LLC | 1.12% | January 10, 2023 | |
| December 13, 2022 | Voleon Capital Management LP | 0.81% | December 22, 2022 | |
| December 12, 2022 | Voleon Capital Management LP | 0.90% | December 22, 2022 | |
| December 9, 2022 | Voleon Capital Management LP | 1.03% | December 22, 2022 | |
| December 9, 2022 | Citadel Advisors LLC | 1.02% | January 10, 2023 | |
| December 8, 2022 | Marshall Wace LLP | 1.50% | August 15, 2023 | |
| December 7, 2022 | Marshall Wace LLP | 1.41% | August 15, 2023 | |
| December 7, 2022 | Voleon Capital Management LP | 0.90% | December 22, 2022 | |
| December 6, 2022 | Marshall Wace LLP | 1.32% | August 15, 2023 | |
| December 6, 2022 | Citadel Advisors LLC | 0.90% | January 10, 2023 | |
| December 6, 2022 | Voleon Capital Management LP | 0.84% | December 22, 2022 | |
| December 5, 2022 | Marshall Wace LLP | 1.21% | August 15, 2023 | |
| December 5, 2022 | Voleon Capital Management LP | 0.74% | December 22, 2022 | |
| December 2, 2022 | Hrteu Limited | 0.48% | December 6, 2022 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 2,528 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.60% of the capital sold short
- Valeo 11.47% of the capital sold short
- Ubisoft Entertainment 10.77% of the capital sold short
- FDJ United 6.58% of the capital sold short
- Teleperformance 5.88% of the capital sold short
- Abivax 5.53% of the capital sold short
- Alstom 4.98% of the capital sold short
- Rémy Cointreau 4.66% of the capital sold short
- Atos Group 3.73% of the capital sold short
- DBV Technologies 3.39% of the capital sold short
- Gecina 3.32% of the capital sold short
- Forvia 3.25% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at October 21, 2026, https://www.quivad.com/action/viridien?page=17